InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,987.61
(
0.06%
)
US TECH 100
20,508.80
(
-0.04%
)
Dow Jones
43,933.36
(
0.05%
)
Brent Oil
72.08
(
0.64%
)
Bitcoin
90,460.68
(
2.89%
)

Replies to post #17994 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #17994 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

jbog

12/06/17 4:21 PM

#17995 RE: indigokid #17994

D) This is Momenta.
icon url

DewDiligence

12/06/17 4:41 PM

#17996 RE: indigokid #17994

My guess is: b). If so, MNTA’s justification could be that MYL’s approval for 40mg Copaxone renders 40mg Glatopa less consequential to MNTA’s business prospects than what is needed to trigger an 8-K.